ARNI — Arno Therapeutics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.11m
Annual cashflow statement for Arno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.91 | -14.4 | -39.7 | 7.77 | -11.5 |
Depreciation | |||||
Non-Cash Items | 1.1 | 4.18 | 24.6 | -24.7 | 1.55 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.039 | 0.777 | 0.781 | -1.92 | -0.02 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -6.83 | -9.42 | -14.2 | -18.8 | -9.97 |
Capital Expenditures | -0.023 | 0 | 0 | -0.02 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | 0 | -0 | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.023 | 0 | 0 | -0.02 | 0 |
Financing Cash Flow Items | 0 | -1.17 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.006 | 13.7 | 30.1 | 0 | 2.08 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6.85 | 4.27 | 15.8 | -18.8 | -7.88 |